FSLD: follistatin-like domain
The medication is administered once a week as a subcutaneous injection, just like insulin injections
The ideas, opinions and suggestions contained on this website are not to be used as a substitute for medical advice, diagnosis or treatment from your doctor for any health condition or problem
Across the three pivotal trials, peak mean body-weight reductions rank retatrutide 12 mg at 24.2% (48 weeks, Phase 2), tirzepatide 15 mg at 22.5% (72 weeks, Phase 3), and semaglutide 2.4 mg at 14.9% (68 weeks, Phase 3) [1][2][5]
We often treat our bodies like high-performance machines, pushing them through grueling workouts and demanding schedules, yet we sometimes forget that the fuel and maintenance we provide must be as high-quality as the effort we exert
The equations of EBGM and ROR are listed in Table 2